Álvaro-Gracia Álvaro, José María
Díaz del Campo Fontecha, Petra
Andréu Sánchez, José Luis
Balsa Criado, Alejandro
Cáliz Cáliz, Rafael
Castrejón Fernández, Isabel
Corominas, Hèctor
Gómez Puerta, José A.
Manrique Arija, Sara
Mena Vázquez, Natalia
Ortiz García, Ana
Plasencia Rodríguez, Chamaida
Silva Fernández, Lucía
Tornero Molina, Jesús
Funding for this research was provided by:
Bristol-Myers Squibb
Theramex
UCB
AbbVie
This article is maintained by: Elsevier
Article Title: Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis
Journal Title: Reumatología Clínica (English Edition)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2024.09.002
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2024.05.007
Content Type: article
Copyright: © 2024 Sociedad Espa�ola de Reumatolog�a (SER), Colegio Mexicano de Reumatolog�a (CMR) and Elsevier Espa�a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.